PROF
Price
$5.50
Change
-$0.05 (-0.90%)
Updated
Aug 1 closing price
Capitalization
205.33M
12 days until earnings call
QTRX
Price
$5.86
Change
-$0.08 (-1.35%)
Updated
Aug 1 closing price
Capitalization
907.82M
9 days until earnings call
Interact to see
Advertisement

PROF vs QTRX

Header iconPROF vs QTRX Comparison
Open Charts PROF vs QTRXBanner chart's image
Profound Medical
Price$5.50
Change-$0.05 (-0.90%)
Volume$19.82K
Capitalization205.33M
Quanterix
Price$5.86
Change-$0.08 (-1.35%)
Volume$553.93K
Capitalization907.82M
PROF vs QTRX Comparison Chart in %
Loading...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PROF vs. QTRX commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PROF is a Hold and QTRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (PROF: $5.56 vs. QTRX: $5.86)
Brand notoriety: PROF and QTRX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: PROF: 91% vs. QTRX: 75%
Market capitalization -- PROF: $205.33M vs. QTRX: $907.82M
PROF [@Medical Specialties] is valued at $205.33M. QTRX’s [@Medical Specialties] market capitalization is $907.82M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PROF’s FA Score shows that 0 FA rating(s) are green whileQTRX’s FA Score has 1 green FA rating(s).

  • PROF’s FA Score: 0 green, 5 red.
  • QTRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both PROF and QTRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PROF’s TA Score shows that 3 TA indicator(s) are bullish while QTRX’s TA Score has 5 bullish TA indicator(s).

  • PROF’s TA Score: 3 bullish, 5 bearish.
  • QTRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QTRX is a better buy in the short-term than PROF.

Price Growth

PROF (@Medical Specialties) experienced а -5.76% price change this week, while QTRX (@Medical Specialties) price change was +0.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.60%. For the same industry, the average monthly price growth was -2.18%, and the average quarterly price growth was -4.69%.

Reported Earning Dates

PROF is expected to report earnings on Oct 30, 2025.

QTRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Specialties (-2.60% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTRX($908M) has a higher market cap than PROF($205M). PROF YTD gains are higher at: -26.764 vs. QTRX (-44.873). PROF has higher annual earnings (EBITDA): -26.78M vs. QTRX (-39.79M). QTRX has more cash in the bank: 321M vs. PROF (26.2M). PROF has less debt than QTRX: PROF (7.94M) vs QTRX (41.5M). QTRX has higher revenues than PROF: QTRX (121M) vs PROF (7.2M).
PROFQTRXPROF / QTRX
Capitalization205M908M23%
EBITDA-26.78M-39.79M67%
Gain YTD-26.764-44.87360%
P/E RatioN/AN/A-
Revenue7.2M121M6%
Total Cash26.2M321M8%
Total Debt7.94M41.5M19%
FUNDAMENTALS RATINGS
PROF vs QTRX: Fundamental Ratings
PROF
QTRX
OUTLOOK RATING
1..100
7266
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
6365
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (29) in the Pharmaceuticals Major industry is in the same range as PROF (41) in the null industry. This means that QTRX’s stock grew similarly to PROF’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PROF (100) in the null industry. This means that QTRX’s stock grew similarly to PROF’s over the last 12 months.

QTRX's SMR Rating (92) in the Pharmaceuticals Major industry is in the same range as PROF (97) in the null industry. This means that QTRX’s stock grew similarly to PROF’s over the last 12 months.

PROF's Price Growth Rating (63) in the null industry is in the same range as QTRX (65) in the Pharmaceuticals Major industry. This means that PROF’s stock grew similarly to QTRX’s over the last 12 months.

PROF's P/E Growth Rating (100) in the null industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that PROF’s stock grew similarly to QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PROFQTRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 15 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASFT0.25N/A
N/A
AppSoft Technologies, Inc.
FTFI30.00N/A
N/A
First Berlin Bancorp, Inc.
ABZPY12.95N/A
N/A
Aboitiz Power Corp.
TEFOF5.06N/A
N/A
Telefonica S.A.
BWEFF3.50N/A
N/A
BW Energy Limited

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and LZAGY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and LZAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-0.90%
LZAGY - PROF
29%
Poorly correlated
-0.14%
A - PROF
27%
Poorly correlated
-1.14%
MTD - PROF
26%
Poorly correlated
-2.95%
NYXH - PROF
25%
Poorly correlated
-2.14%
QTRX - PROF
25%
Poorly correlated
-1.35%
More